These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 33181169)
1. Transcutaneous application of the gaseous CO Finžgar M; Frangež HB; Cankar K; Frangež I Microvasc Res; 2021 Jan; 133():104100. PubMed ID: 33181169 [TBL] [Abstract][Full Text] [Related]
2. Effect of transcutaneous application of gaseous carbon dioxide on cutaneous microcirculation. Finzgar M; Melik Z; Cankar K Clin Hemorheol Microcirc; 2015; 60(4):423-35. PubMed ID: 25261433 [TBL] [Abstract][Full Text] [Related]
3. Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study. Rathsman B; Jensen-Urstad K; Nyström T Diabetologia; 2014 Aug; 57(8):1703-10. PubMed ID: 24802206 [TBL] [Abstract][Full Text] [Related]
4. Microvascular alterations in diabetic microangiopathy: topical treatment with Essaven gel--a placebo-controlled, randomized study. Incandela L; Belcaro G; Cesarone MR; De Sanctis MT; Griffin M Angiology; 2001 Dec; 52 Suppl 3():S35-41. PubMed ID: 11775647 [TBL] [Abstract][Full Text] [Related]
5. Cutaneous iontophoresis of treprostinil, a prostacyclin analog, increases microvascular blood flux in diabetic malleolus area. Hellmann M; Roustit M; Gaillard-Bigot F; Cracowski JL Eur J Pharmacol; 2015 Jul; 758():123-8. PubMed ID: 25843412 [TBL] [Abstract][Full Text] [Related]
6. Post-occlusive reactive hyperaemia of skin microvasculature and foot complications in type 2 diabetes. Lanting SM; Barwick AL; Twigg SM; Johnson NA; Baker MK; Chiu SK; Caterson ID; Chuter VH J Diabetes Complications; 2017 Aug; 31(8):1305-1310. PubMed ID: 28545894 [TBL] [Abstract][Full Text] [Related]
7. The effect of transcutaneous application of gaseous CO Macura M; Ban Frangez H; Cankar K; Finžgar M; Frangez I Int Wound J; 2020 Dec; 17(6):1607-1614. PubMed ID: 32633896 [TBL] [Abstract][Full Text] [Related]
8. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease. Edvinsson LI; Edvinsson ML; Angus Deveber G Int Angiol; 2003 Jun; 22(2):141-7. PubMed ID: 12865879 [TBL] [Abstract][Full Text] [Related]
9. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers. Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012 [TBL] [Abstract][Full Text] [Related]
10. [CO2-induced acral blood flow and the oxygen partial pressure in arterial occlusive disease]. Hartmann B; Drews B; Bassenge E Dtsch Med Wochenschr; 1991 Oct; 116(43):1617-21. PubMed ID: 1935632 [TBL] [Abstract][Full Text] [Related]
11. Differences in skin blood flow oscillations between the plantar and dorsal foot in people with diabetes mellitus and peripheral neuropathy. Jan YK; Liao F; Cheing GLY; Pu F; Ren W; Choi HMC Microvasc Res; 2019 Mar; 122():45-51. PubMed ID: 30414870 [TBL] [Abstract][Full Text] [Related]
12. The effect of glibenclamide on cutaneous laser-Doppler flux. Cankar K; Strucl M Microvasc Res; 2008 Jan; 75(1):97-103. PubMed ID: 17675187 [TBL] [Abstract][Full Text] [Related]
13. Spectral analysis of the blood flow in the foot microvascular bed during thermal testing in patients with diabetes mellitus. Mizeva I; Zharkikh E; Dremin V; Zherebtsov E; Makovik I; Potapova E; Dunaev A Microvasc Res; 2018 Nov; 120():13-20. PubMed ID: 29802880 [TBL] [Abstract][Full Text] [Related]
14. Why critical limb ischemia criteria are not applicable to diabetic foot and what the consequences are. Jörneskog G Scand J Surg; 2012; 101(2):114-8. PubMed ID: 22623444 [TBL] [Abstract][Full Text] [Related]
15. Two-week topical treatment with Essaven gel in patients with diabetic microangiopathy--a placebo-controlled, randomized study. Cesarone MR; Incandela L; Belcaro G; De Sanctis MT; Ricci A; Griffin M Angiology; 2001 Dec; 52 Suppl 3():S43-8. PubMed ID: 11775648 [TBL] [Abstract][Full Text] [Related]
16. Impaired microvascular flow motion in subclinical diabetic feet with sudomotor dysfunction. Sun PC; Chen CS; Kuo CD; Lin HD; Chan RC; Kao MJ; Wei SH Microvasc Res; 2012 Mar; 83(2):243-8. PubMed ID: 21722653 [TBL] [Abstract][Full Text] [Related]
17. Effect of carbon dioxide-enriched water and fresh water on the cutaneous microcirculation and oxygen tension in the skin of the foot. Hartmann BR; Bassenge E; Pittler M Angiology; 1997 Apr; 48(4):337-43. PubMed ID: 9112881 [TBL] [Abstract][Full Text] [Related]
18. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. Arora S; Pomposelli F; LoGerfo FW; Veves A J Vasc Surg; 2002 Mar; 35(3):501-5. PubMed ID: 11877698 [TBL] [Abstract][Full Text] [Related]
19. In diabetic Charcot neuroarthropathy impaired microvascular function is related to long lasting metabolic control and low grade inflammatory process. Araszkiewicz A; Soska J; Borucka K; Olszewska M; Niedzwiecki P; Wierusz-Wysocka B; Zozulinska-Ziolkiewicz D Microvasc Res; 2015 Sep; 101():143-7. PubMed ID: 26239695 [TBL] [Abstract][Full Text] [Related]
20. Low molecular weight heparin seems to improve local capillary circulation and healing of chronic foot ulcers in diabetic patients. Jörneskog G; Brismar K; Fagrell B Vasa; 1993; 22(2):137-42. PubMed ID: 8391741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]